Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management
J Kabeerdoss, RK Pilania, R Karkhele… - Rheumatology …, 2021 - Springer
Multisystem inflammatory syndrome (MIS-C) is a pediatric hyperinflammation disorder
caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It has now been …
caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It has now been …
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Many public health responses and modeled scenarios for COVID-19 outbreaks caused by
SARS-CoV-2 assume that infection results in an immune response that protects individuals …
SARS-CoV-2 assume that infection results in an immune response that protects individuals …
[HTML][HTML] Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
EM Anderson, EC Goodwin, A Verma, CP Arevalo… - Cell, 2021 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread within
the human population. Although SARS-CoV-2 is a novel coronavirus, most humans had …
the human population. Although SARS-CoV-2 is a novel coronavirus, most humans had …
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
KW Ng, N Faulkner, GH Cornish, A Rosa, R Harvey… - Science, 2020 - science.org
Zoonotic introduction of novel coronaviruses may encounter preexisting immunity in
humans. Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we …
humans. Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we …
Seasonal coronavirus protective immunity is short-lasting
A key unsolved question in the current coronavirus disease 2019 (COVID-19) pandemic is
the duration of acquired immunity. Insights from infections with the four seasonal human …
the duration of acquired immunity. Insights from infections with the four seasonal human …
COVID-19: Immunology and treatment options
S Felsenstein, JA Herbert, PS McNamara… - Clinical …, 2020 - Elsevier
The novel coronavirus SARS-CoV2 causes COVID-19, a pandemic threatening millions. As
protective immunity does not exist in humans and the virus is capable of escaping innate …
protective immunity does not exist in humans and the virus is capable of escaping innate …
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
emerged during the current coronavirus disease 2019 (COVID-19) pandemic. Although …
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
P Kellam, W Barclay - Journal of General Virology, 2020 - microbiologyresearch.org
SARS-CoV-2 is a novel coronavirus that is the causative agent of coronavirus infectious
disease 2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in …
disease 2019 (COVID-19). As of 17 April 2020, it has infected 2 114 269 people, resulting in …
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
AJ Brown, JJ Won, RL Graham, KH Dinnon III, AC Sims… - Antiviral research, 2019 - Elsevier
Abstract The genetically diverse Orthocoronavirinae (CoV) family is prone to cross species
transmission and disease emergence in both humans and livestock. Viruses similar to …
transmission and disease emergence in both humans and livestock. Viruses similar to …
Hosts and sources of endemic human coronaviruses
The four endemic human coronaviruses HCoV-229E,-NL63,-OC43, and-HKU1 contribute a
considerable share of upper and lower respiratory tract infections in adults and children …
considerable share of upper and lower respiratory tract infections in adults and children …